Terms: = Sarcomas AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
103 results:
1. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.
Takeda T; Tsubaki M; Genno S; Tomita K; Nishida S
Exp Cell Res; 2024 Mar; 436(2):113978. PubMed ID: 38382805
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.
Cai F; Liu L; Bo Y; Yan W; Tao X; Peng Y; Zhang Z; Liao Q; Yi Y
BMC Cancer; 2024 Feb; 24(1):166. PubMed ID: 38308235
[TBL] [Abstract] [Full Text] [Related]
3. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract] [Full Text] [Related]
4. Epithelial to mesenchymal transition (emt) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract] [Full Text] [Related]
5. Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
6. New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract] [Full Text] [Related]
7. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract] [Full Text] [Related]
8. VAMP8 suppresses the metastasis via DDX5/β-catenin signal pathway in osteosarcoma.
Yang S; Zhou P; Zhang L; Xie X; Zhang Y; Bo K; Xue J; Zhang W; Liao F; Xu P; Hu Y; Yan R; Liu D; Chang J; Zhou K
Cancer Biol Ther; 2023 Dec; 24(1):2230641. PubMed ID: 37405957
[TBL] [Abstract] [Full Text] [Related]
9. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/emt pathway and associates with clinical prognosis and immune infiltration.
Han GD; Dai J; Hui HX; Zhu J
J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
[TBL] [Abstract] [Full Text] [Related]
10. Nε-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Arch Toxicol; 2023 Aug; 97(8):2231-2244. PubMed ID: 37314482
[TBL] [Abstract] [Full Text] [Related]
11. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract] [Full Text] [Related]
12. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract] [Full Text] [Related]
13. Identification of an emt-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract] [Full Text] [Related]
14. Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line.
Hodge MA; Miller T; Weinman MA; Wustefeld-Janssens B; Bracha S; Davis BW
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980828
[TBL] [Abstract] [Full Text] [Related]
15. Long Noncoding RNA PCGEM1 Facilitates Tumor Growth and Metastasis of Osteosarcoma by Sponging miR-433-3p and Targeting OMA1.
Li J; Zhang Y; Sun F; Zhang G; Pan XA; Zhou Q
Orthop Surg; 2023 Apr; 15(4):1060-1071. PubMed ID: 36782343
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway.
Sun MX; An HY; Sun YB; Sun YB; Bai B
J Orthop Surg Res; 2022 Dec; 17(1):557. PubMed ID: 36544170
[TBL] [Abstract] [Full Text] [Related]
17. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical expressions of emt markers in pan-RAS-pERK1/2-positive tumors improve diagnosis and prognosis assessment of non-muscle invasive bladder cancer and muscle invasive bladder cancer patients.
Tripathi K; Maurya N; Goel A; Singhai A; Garg M
Mol Cell Biochem; 2023 Jun; 478(6):1169-1190. PubMed ID: 36239855
[TBL] [Abstract] [Full Text] [Related]
19. Pseudoangiosarcomatous squamous cell carcinoma: a rare subtype of squamous cell carcinoma that needs to be differentiated from angiosarcoma and has a poor prognosis.
Zhan Y; Wan H; Wu L; Ge X; Xie X; Wu L; Cai Y
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):62-66. PubMed ID: 36227677
[TBL] [Abstract] [Full Text] [Related]
20. Classical epithelial-mesenchymal transition (emt) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
Jinesh GG; Brohl AS
Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218
[TBL] [Abstract] [Full Text] [Related]
[Next]
